BamSEC and AlphaSense Join Forces
Learn More

Allogene Therapeutics Inc.

NASDAQ: ALLO    
Share price (12/20/24): $1.87    
Market cap (12/20/24): $392 million

Indentures Filter

EX-4.11
from S-3 20 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.10
from S-3 22 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.9
from S-3 21 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.6
from S-3 53 pages Allogene Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.3
from 10-K 4 pages Description of Common Stock
12/34/56
EX-4.12
from S-3ASR 20 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.11
from S-3ASR 22 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.10
from S-3ASR 21 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 54 pages Allogene Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.3
from 10-K ~5 pages Description of Common Stock
12/34/56
EX-4.11
from S-3ASR 20 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.10
from S-3ASR 22 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.9
from S-3ASR 21 pages Allogene Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Allogene Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 58 pages Allogene Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 105 pages Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS 50 pages Investors’ Rights Agreement
12/34/56